Retinal Physician
   

 

 

 

 




Exploring How New Imaging Modalities Can Change Patient Care
By: Jeffrey S. Heier, M.D.
January 2008

The Next Step in OCT Technology
By: Peter K. Kaiser, M.D.
Spectral domain provides unprecedented views of the retina
January 2008

Combination Instrument Enhances Patient Care
By: Scott W. Cousins, MD
A Duke University physician describes his experience with multi-modality imaging
January 2008

Utilizing a Multi-Modality Imaging Instrument
A panel of experts discusses capabilities, efficiency and applications
January 2008

Upfront
By: Jason S. Slakter, M.D.
From the editor-in-chief
January 2008

Subspecialty News
Genentech defends its position on Avastin and compounding pharmacies and more
January 2008

Face Off
By: Abdhish R. Bhavsar, M.D.
NSAIDs for post-vitrectomy and scleral buckle cases
January 2008

Coding Q&A
By: Riva Lee Asbell
Update on extended ophthalmoscopy
January 2008

Clinical Trial Spotlight
By: Andrew E. Mathis, PhD, Medical Editor
The CATT trial
January 2008

Inflammation and Age-related Macular Degeneration
By: Jayakrishna Ambati, MD
New research expands understanding of how inflammation and the complement system contribute to AMD disease progression
January 2008

Bevacizumab vs Triamcinolone for Diabetic Macular Edema
By: Mark Gillies, PhD, FRANZCO
Look before you leap
January 2008

Combination Treatments for CNV in AMD
By: Peter K. Kaiser, M.D.
Early reports show promising results with several combinations of therapies
January 2008

Comorbid Conditions in Vitreoretinal Surgery
By: Shawn Wilker, MD; Julia A. Haller, MD; Diana V. Do, MD
Awareness of existing health conditions improves surgical results
January 2008

OCT Imaging: Advances Over the Past 5 Years and Beyond
By: Henry Alexander Leder, MD; Scott W. Cousins, MD
Optical coherence technology has come a long way, and it continues to move forward
January 2008

Treatments on the Horizon for AMD Highlighted at RPS
Research is going beyond anti-VEGF to novel approaches to wet and dry AMD
January 2008

PrONTO Boosts Hope for Variable Dosing of Ranibizumab
OCT-guided therapy may reduce frequency of injections for some patients
January 2008

What Lies Beyond VEGF in the Treatment of PDR and DME?
Highlights from the Annual Charles L. Schepens Lecture
January 2008

IVTA to the Rescue?
Triamcinolone tested for ranibizumab failure
January 2008

VEGF Trap Phase 2 Study Shows Efficacy, Safety
CLEAR-IT 2 Primary Endpoint Results Disclosed
January 2008

Retisert Reimplantation Appears Safe and Effective
Similar control of inflammation seen, as from first procedure
January 2008

Study Seeks to Prove Safety and Efficacy of 2.5-mg Bevacizumab
Higher dosing may offer trend toward improved VA, less frequent injections
January 2008

Sterile Endophthalmitis After Intravitreal Triamcinolone
Inflammation following injections is not always a result of preservatives
January 2008

Is Scleral Buckling on the Endangered Species List?
Retinal specialist argues that PPV is making this procedure obsolete
January 2008

Glycemic Control a Possible Factor in DR Progression
A trend in lower rates in diabetic retinopathy may be indicative of better diabetes management
January 2008

Triple Therapy for Wet AMD Shows Impressive Results
Dynamic disease requires complex approach
January 2008

Upfront
By: Jason S. Slakter, M.D.
From the editor-in-chief
January 2008

Guest Editorial
By: Charles C. Barr, MD
Reflections on a Unique Group of Physicians
January 2008

Subspecialty News
By: Jerry Helzner, Senior Editor
OPKO’s SiRNA drug for AMD shows promise and more
January 2008

Coding Q&A
By: Riva Lee Asbell
CPT codes for retinal procedures are changed for 2008
January 2008

Proliferative Vitreoretinopathy
By: Marc J. Spirn, MD; Carl D. Regillo, M.D.
January 2008

Retinal and Uveal Drug Toxicity
By: Esther Kim, BA; Howard F Fine, MD, MHSc; Michael D. Ober, MD
January 2008

Point/Counterpoint
By: John S. Pollack, MD
23-g vs. 25-g vitrectomy surgery
January 2008

Why (and When) I Prefer 25-g Vitrectomy
By: Carl C. Awh, M.D.
January 2008

Transient Monocular Visual Loss Due to Primary Vasospasm: A Case Study
By: Jacqueline M.S. Winterkorn, MD, PhD
January 2008

A Pixel Is Worth a Thousand Words
By: David Heiden, MD
The Development of Ophthalmic Imaging and OCT
January 2008

Retina Ambulatory Surgery Center Myths Debunked
By: Pravin U. Dugel, MD; Michael A. Romansky, J.D. ; Steve Charles, MD
January 2008

Retinal Regeneration Study Shows Encouraging Early Results
By: Rochelle Nataloni, Contributing Editor
Phase 1 trial demonstrates therapeutic benefit without damage to the targeted structure
January 2008

Clinical Trial Update
January 2008

|
© Wolters Kluwer Pharma Solutions, Inc.|VisionCare Group
All Rights Reserved - Terms and Conditions of Service